The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Context Therapeutics Inc.(NASDAQ:CNTX) 
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a selective potent antagonist of the progesterone receptor that is linked to resis...
Website: http://www.contexttherapeutics.com
Founded: 2015
CEO: Martin Lehr
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Context Therapeutics Days Payable Outstanding ttm (DPO)
Context Therapeutics Op Cashflow Per Share ttm
Context Therapeutics Free Cashflow Per Share ttm
Context Therapeutics Cash Per Share ttm
Context Therapeutics (GAAP) P/E ratio ttm
Context Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.